Eaton Vance Tax Advantaged Dividend (EVT) 20.85 $E
Post# of 273249
Distribution Dates and Amounts Announced for Eaton Vance Closed-End Funds
PR Newswire - Thu Sep 01, 3:54PM CDT
Eaton Vance closed-end funds (the "Funds" announced distributions today as detailed below.
ENX: 14.17 (+0.15), ETO: 22.20 (+0.13), EVV: 13.67 (-0.01), ETV: 15.03 (-0.04), EVT: 20.85 (+0.11), EIA: 13.27 (-0.05), ETY: 10.92 (+0.07), EHT: 10.10 (-0.01), EOI: 13.10 (unch), ETW: 11.09 (+0.08), MMV: 15.11 (+0.02), ETX: 21.24 (+0.39), EVY: 15.34 (+0.13), MIW: 15.25 (-0.05), EMJ: 16.05 (+0.43), EIO: 15.00 (-0.07), EXG: 8.99 (+0.09), EIM: 13.90 (+0.16), EMI: 14.35 (-0.01), ETG: 15.27 (+0.06), EXD: 12.43 (+0.06), EVF: 6.26 (+0.01), EVG: 13.67 (+0.02), ETJ: 9.73 (+0.03), EIP: 14.85 (+0.07), EFT: 14.05 (+0.02), EVJ: 14.34 (+0.14), EFR: 13.72 (+0.02), EV: 39.76 (-0.37), EOT: 23.14 (+0.23), NYH: 13.84 (+0.08), EVN: 14.55 (+0.10), EVM: 13.73 (+0.10), EVP: 13.49 (+0.03), CEV: 14.48 (+0.03), ETB: 16.47 (+0.01), EVO: 15.72 (+0.06), EOS: 13.63 (+0.07), EIV: 13.73 (+0.17), MAB: 15.50 (+0.02), EFF: 15.55 (-0.04)
Eaton Vance Closed-End Funds Release Estimated Sources Of Distributions
PR Newswire - Wed Aug 31, 1:25PM CDT
The Eaton Vance closed-end funds listed below released today the estimated sources of their August distributions (each a "Fund". This press release is issued as required by the Funds' managed distribution plan (Plan) and an exemptive order received from the U.S. Securities and Exchange Commission. The Board of Trustees has approved the implementation of the Plan to make monthly or quarterly, as noted below, cash distributions to common shareholders, stated in terms of a fixed amount per common share. This information is sent to you for informational purposes only and is an estimate of the sources of the August distribution. It is not determinative of the tax character of a Fund's distributions for the 2016 calendar year. Shareholders should note that each Fund's total regular distribution amount is subject to change as a result of market conditions or other factors.
EXG: 8.99 (+0.09), ETO: 22.20 (+0.13), ETV: 15.03 (-0.04), EVT: 20.85 (+0.11), EVG: 13.67 (+0.02), ETJ: 9.73 (+0.03), ETY: 10.92 (+0.07), ETW: 11.09 (+0.08), EOI: 13.10 (unch), EV: 39.76 (-0.37), ETB: 16.47 (+0.01), EOS: 13.63 (+0.07)
/C O R R E C T I O N -- Eaton Vance Management/
PR Newswire - Thu Oct 01, 4:18PM CDT
In the news release, Eaton Vance Closed-End Funds Release Estimated Sources Of Distributions, issued 30-Sep-2015 by Eaton Vance Management over PR Newswire, we are advised by the company that the Eaton Vance Tax-Advantaged Dividend Income Fund (NYSE: EVT) table has been updated. The complete, corrected release follows:
EXG: 8.99 (+0.09), ETO: 22.20 (+0.13), EXD: 12.43 (+0.06), ETV: 15.03 (-0.04), EVT: 20.85 (+0.11), EVG: 13.67 (+0.02), ETJ: 9.73 (+0.03), ETY: 10.92 (+0.07), ETW: 11.09 (+0.08), EOI: 13.10 (unch), EV: 39.76 (-0.37), ETB: 16.47 (+0.01), EOS: 13.63 (+0.07)
Evotec to Present at Two Upcoming IR Conferences
GlobeNewswire - Thu Sep 10, 8:33AM CDT
Evotec AG (Frankfurt:EVT) (TecDAX, ISIN: DE0005664809) announced today that its CEO, Dr Werner Lanthaler, will present at the Morgan Stanley Global Healthcare Conference in New York, USA, and at the Berenberg & Goldman Sachs Fourth Annual German Corporate Conference, Munich, Germany.
EVT: 20.85 (+0.11), MS: 31.75 (-0.14)
Evotec Enters Into Licence and Collaboration Agreement With Pfizer Inc. in Tissue Fibrosis
GlobeNewswire - Wed Sep 09, 12:38AM CDT
Evotec AG (Frankfurt:EVT) (TecDAX) (ISINE0005664809) today announced that it has signed an agreement on a four-year research collaboration with Pfizer Inc. in the field of tissue fibrosis.
EVT: 20.85 (+0.11), PFE: 34.77 (unch)